Literature DB >> 10423237

Structural investigation on the requirement of CCHH zinc finger type in nucleocapsid protein of human immunodeficiency virus 1.

S Ramboarina1, N Morellet, M C Fournié-Zaluski, B P Roques, N Moreller.   

Abstract

The nucleocapsid proteins (NCps) of lentiviruses play a key role during the retroviral replication cycle. NCps contain one or two highly conserved domains characterized by a CX(2)CX(4)HX(4)C sequence which binds zinc with a high affinity. The reasons of the high conservation of zinc fingers of CCHC type in lentiviruses were investigated by a structural study of mutants in which the zinc-coordinated ligands were exchanged. The HCHC form was unable to bind zinc tetrahedrally, whereas in His(28)(13-30)NCp7 corresponding to the CCHH motif, the zinc was tightly complexed. The mutant peptide exists in two interconverting conformations E and D [DeltaG(DE) (293K) = 0.1 kcal/mol] arising from the zinc coordination of His(28), by either its Nepsilon2 or its Ndelta1, respectively. As compared to the native CCHC zinc finger, the Cys(28) --> His mutation induces structural changes in the finger due to a modification in the coordination state of His(23) bound to zinc by Nepsilon2 in the wild-type finger by Ndelta1 in both conformers of the mutant. Introduction of these single mutations within the NCp7 proximal zinc finger in the HIV-1 genome was very recently shown to result in a loss of viral infection. This supports the hypothesis that structural changes of the zinc finger domain of NCp7 inhibit the recognition of one or several targets critically involved in the virus life cycle.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10423237     DOI: 10.1021/bi9905258

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Subtle alterations of the native zinc finger structures have dramatic effects on the nucleic acid chaperone activity of human immunodeficiency virus type 1 nucleocapsid protein.

Authors:  Jianhui Guo; Tiyun Wu; Bradley F Kane; Donald G Johnson; Louis E Henderson; Robert J Gorelick; Judith G Levin
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Structure of Clostridium difficile PilJ exhibits unprecedented divergence from known type IV pilins.

Authors:  Kurt H Piepenbrink; Grace A Maldarelli; Claudia F Martinez de la Peña; George L Mulvey; Greg A Snyder; Leon De Masi; Erik C von Rosenvinge; Sebastian Günther; Glen D Armstrong; Michael S Donnenberg; Eric J Sundberg
Journal:  J Biol Chem       Date:  2013-12-21       Impact factor: 5.157

3.  Cysteine 155 plays an important role in the assembly of Mycobacterium tuberculosis FtsZ.

Authors:  Richa Jaiswal; Dulal Panda
Journal:  Protein Sci       Date:  2008-05       Impact factor: 6.725

4.  Arterivirus subgenomic mRNA synthesis and virion biogenesis depend on the multifunctional nsp1 autoprotease.

Authors:  Marieke A Tijms; Danny D Nedialkova; Jessika C Zevenhoven-Dobbe; Alexander E Gorbalenya; Eric J Snijder
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA.

Authors:  James S Buckman; William J Bosche; Robert J Gorelick
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Target specificity of human immunodeficiency virus type 1 NCp7 requires an intact conformation of its CCHC N-terminal zinc finger.

Authors:  S Ramboarina; S Druillennec; N Morellet; S Bouaziz; B P Roques
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 7.  Cysteine-modifying agents: a possible approach for effective anticancer and antiviral drugs.

Authors:  Angela Casini; Andrea Scozzafava; Claudiu T Supuran
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

8.  Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus.

Authors:  T L Hartman; L Yang; A N Helfrick; M Hassink; N I Shank; K George Rosenker; M T Scerba; M Saha; E Hughes; A Q Wang; X Xu; P Gupta; R W Buckheit; D H Appella
Journal:  Antiviral Res       Date:  2016-08-26       Impact factor: 5.970

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.